| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 124.996 | 78 |
| GSM780708 | Untreated after 4 days (C2_1) | 97.9003 | 75 |
| GSM780709 | Untreated after 4 days (C3_1) | 93.1451 | 74 |
| GSM780719 | Untreated after 4 days (C1_2) | 130.617 | 79 |
| GSM780720 | Untreated after 4 days (C2_2) | 99.8348 | 75 |
| GSM780721 | Untreated after 4 days (C3_2) | 110.253 | 77 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 89.472 | 74 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 109.013 | 76 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 103.299 | 76 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 97.1016 | 75 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 124.107 | 78 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 111.11 | 77 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 119.465 | 78 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 94.3005 | 74 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 124.209 | 78 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 109.679 | 77 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 103.431 | 76 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 116.481 | 77 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 117.143 | 77 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 109.392 | 76 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 108.834 | 76 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 120.146 | 78 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 111.494 | 77 |